Video

Dr Bruce Sands on JAK Inhibitors for IBD

02/04/2019

 

In this video, Dr Bruce Sands discusses the current role of JAK inhibitors for the treatment of IBD and whether or not gastroenterologists should be concerned with adverse events.

 

For more videos, visit the AIBD Newsroom.

 

 

Published in partnership with AIBD

 

 

Related Content

Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Hudesman, MD, on Managing IBD and Malignancy
02/12/2006
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.
02/12/2006
Ulcerative Colitis
aibd
Ulcerative Colitis
Severe, refractory, hospitalized ulcerative colitis patients should only be treated with medical therapy
08/15/2018
08/15/2018
Stress and Burnout
Stress and Burnout
David Hudesman, MD, on Reducing Stress and Risk Among Staff
04/27/2020
In this video, Gastroenterology Consultant Advisory Board Member David Hudesman, MD, talks about how his staff is coping with COVID-19 challenges, as well as how he helps his staff reduce stress and risk of...
04/27/2020
Inflammatory Bowel Disease
Bruce Sands, MD
Inflammatory Bowel Disease
Bruce Sands, MD, MS, on When to Recommend a JAK Inhibitor for IBD
06/25/2019
In this video, Bruce Sands, MD, MS, from the Icahn School of Medicine at Mount Sinai, discusses when a gastroenterologist should recommend a JAK inhibitor for the treatment of ulcerative colitis.
06/25/2019
Cardiometabolic Risk
Cardiometabolic Risk
William E. Boden, MD, on A New Risk Score for Mortality and Myocardial Infarction in Patients With Stable Coronary Artery Disease: The COURAGE Risk Prediction Tool
08/10/2020
In this video, William Boden, MD, explains how the COURAGE Risk Prediction Tool works and what its impact can be on treatment optimization.
08/10/2020